VRX Related Downgrades

May 20, 2013 11:43 AM UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through

Sep 14, 2012 02:17 PM Morgan Stanley Downgrades Valeant Pharmaceuticals (VRX) to Equalweight

Sep 5, 2012 08:37 AM Goldman Sachs Downgrades Medicis (MRX) to Neutral; Limited Upside From Deal Now

May 3, 2012 02:08 PM CRT Capital Cuts Valeant Pharma (VRX) to Fairly Valued

Jan 26, 2012 08:44 AM Piper Jaffray Downgrades Valeant Pharmaceuticals (VRX) to Neutral

Mar 31, 2011 10:06 AM UPDATE - UBS Downgraded Cephalon (CEPH) to Neutral; Likely Some Upside To Offer price, but Not Material

Mar 31, 2011 07:31 AM UBS Downgrades Cephalon (CEPH) to Neutral

Mar 30, 2011 01:58 PM Stifel Nicolaus Cuts Cephalon (CEPH) to Hold

Mar 30, 2011 07:44 AM Morgan Stanley Upgrades Cephalon (CEPH), JMP Downgrades to Market Perform

Feb 1, 2011 03:17 PM Hearing Valeant Pharmaceuticals (VRX) Downgraded at BofA/Merrill Lynch

Nov 4, 2010 03:45 PM BofA Merrill Cuts Valeant (VRX) to Neutral Following Q3 Earnings Report

Jun 22, 2010 07:30 AM Piper Jaffray Downgrades Biovail (BVF) to Neutral Following Merger Announcement

Jul 9, 2009 09:09 AM Leerink Swann Downgrades Valeant Pharmaceuticals (VRX) to Market Perform; Adjusts Q2 Estimates

Jun 9, 2009 08:00 AM Wachovia Downgrades Valeant Pharmaceuticals (VRX) to Underperform; Risk/Reward Unfavorable

Oct 2, 2008 10:44 AM Matrix USA Rating Changes 10/2

Aug 25, 2008 09:24 AM Matrix USA Rating Changes 8/25

May 28, 2008 10:17 AM Matrix USA Rating Changes 5/28

May 21, 2008 10:27 AM Matrix USA Rating Changes 5/21

Mar 10, 2008 10:17 AM Matrix USA Rating Changes 3/10

Feb 29, 2008 12:18 PM Matrix USA Rating Changes 2/29

Feb 29, 2008 09:23 AM Merrill Lynch Downgrades Valeant Pharmaceuticals (VRX) to Neutral

Dec 10, 2007 09:13 AM Matrix USA Rating Changes 12/10

Nov 15, 2007 09:16 AM Matrix USA Rating Changes 11/15

Nov 5, 2007 08:54 AM Bear Stearns downgrades Valeant Pharmaceuticals (VRX) to Underperform

Sep 13, 2006 10:00 AM Lazard Capital Downgrades Valeant Pharmaceuticals (VRX) to Hold

Apr 4, 2006 07:31 AM Piper Jaffray downgrades Valeant Phama (VRX) to Market Perform

Apr 4, 2006 07:14 AM Piper Jaffray Downgrades Valeant Pharmaceuticals (VRX) to Market Perform